Chronic Myelomonocytic Leukemia - 30 Studies Found
| Completed |
: Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML) : Chronic Myelomonocytic Leukemia : 2010-04-01 : Drug: Decitabine 20mg/m2/day, one hour intravenous infusion, every day during 5 days |
| Active, not recruiting |
: Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2010-12-01 : Drug: Decitabine Decitabine will be administered at a dose of 20 mg/m2 infused over a 1 hour period once |
| Completed |
: A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2011-04-29 : Drug: 5-Azacitidine Administered on Days 1-7 of each Cycle |
| Completed |
: Lenalidomide in Patients With Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2011-05-09 : Drug: Revlimid Dose escalation 5mg - 10mg - 15mg - 20mg in |
| Recruiting |
: The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2009-11-06 |
| Recruiting |
: Study of Lenzilumab (KB003) in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) : Chronic Myelomonocytic Leukemia (CMML) : 2015-08-27 : Drug: lenzilumab Other Names:
|
| Recruiting |
: Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia : Leukemia, Myelomonocytic, Chronic : 2016-06-15 : Drug: Tipifarnib Oral tablet Other Names: |
| Recruiting |
: A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) : Leukemia, Myelomonocytic, Chronic : 2017-01-24 :
|
| Completed |
: Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia :
|
| Terminated |
: Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) :
: 2003-12-19 : Drug: DTGM Starting dose: 2 mcg/kg by vein three times a week (M,W,F) for two consecutive weeks. |